Study of Tremelimumab in Patients With Advanced Solid Tumors

Clinical trial NCT02527434 · COMPLETED

Trial details

NCT number: NCT02527434
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Bladder Cancer Triple-negative Breast Cancer Pancreatic Ductal Adenocarcinoma

Start date: 2015-11-02
Primary completion: 2018-02-17
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.